GGrantIndex
← Leaderboards

Thomas G. Diacovo

Washington University

$10,076,014
Attributed
$12,227,508
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$12,227,508 · 8

By mechanism

R01$11,883,388 · 6
R56$239,250 · 1
K08$104,870 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Animal Model

Research focus

Animal ModelResponseThrombosisBaseAdhesionsEventSitePharmaceutical PreparationsIntravital MicroscopyIn VitroIn VivoSurfaceBlood PlateletsBlood VesselsAnimalsThrombusPreventVon Willebrand FactorClinical TrialsMediatingBloodDesignInjuredSignal Pathway

Grant awards (33)

Targeting the Thromboinflammatory Response to Mitigate Bowel Injury in Necrotizing Enterocolitis$239,250
R56 · FY2023 · HD · contact PI
Neonatal and Pediatric Platelet Function and Pharmacology$510,415
R01 · FY2019 · HD · contact PI
Neonatal and Pediatric Platelet Function and Pharmacology$525,185
R01 · FY2018 · HD · contact PI
Neonatal and Pediatric Platelet Function and Pharmacology$248,860
R01 · FY2017 · HD · contact PI
Neonatal and Pediatric Platelet Function and Pharmacology$514,346
R01 · FY2016 · HD · contact PI
Targeting non-classical oncogenes as therapy for T-ALL$332,000
R01 · FY2016 · CA · contact PI
Neonatal and Pediatric Platelet Function and Pharmacology$535,146
R01 · FY2015 · HD · contact PI
Targeting non-classical oncogenes as therapy for T-ALL$332,000
R01 · FY2015 · CA · contact PI
Model of Platelet Adhesion and Thrombus Formation$395,048
R01 · FY2014 · HL
Targeting non-classical oncogenes as therapy for T-ALL$322,040
R01 · FY2014 · CA · contact PI
GPIb Alpha-VWF-A1 bond kinetics in health and disease$379,348
R01 · FY2013 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$375,127
R01 · FY2013 · HL
Targeting non-classical oncogenes as therapy for T-ALL$312,080
R01 · FY2013 · CA · contact PI
GPIb Alpha-VWF-A1 bond kinetics in health and disease$398,475
R01 · FY2012 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$393,081
R01 · FY2012 · HL
Targeting non-classical oncogenes as therapy for T-ALL$332,000
R01 · FY2012 · CA · contact PI
GPIb Alpha-VWF-A1 bond kinetics in health and disease$402,500
R01 · FY2011 · HL · contact PI
Model of Platelet Adhesion and Thrombus Formation$396,130
R01 · FY2011 · HL
Model of Platelet Adhesion and Thrombus Formation$409,651
R01 · FY2010 · HL
GPIb Alpha-VWF-A1 bond kinetics in health and disease$409,269
R01 · FY2010 · HL · contact PI
P13Kdelta Modulation of Neutrophil Trafficking$343,477
R01 · FY2008 · HL · contact PI
Structure/Functional Characterization of vWF-A1 Domain$381,642
R01 · FY2007 · HL · contact PI
P13Kdelta Modulation of Neutrophil Trafficking$343,477
R01 · FY2007 · HL · contact PI
Structure/Functional Characterization of vWF-A1 Domain$393,041
R01 · FY2006 · HL · contact PI
P13Kdelta Modulation of Neutrophil Trafficking$353,736
R01 · FY2006 · HL · contact PI
Structure/Functional Characterization of vWF-A1 Domain$402,500
R01 · FY2005 · HL
P13Kdelta Modulation of Neutrophil Trafficking$362,250
R01 · FY2005 · HL
Structure/Functional Characterization of vWF-A1 Domain$382,500
R01 · FY2004 · HL
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF VWF-AL DOMAIN$390,000
R01 · FY2003 · HL
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF VWF-AL DOMAIN$390,000
R01 · FY2002 · HL
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF VWF-AL DOMAIN$390,000
R01 · FY2001 · HL
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF VWF-AL DOMAIN$228,064
R01 · FY2000 · HL
CHARACTERIZATION OF PLATELET:LEUKOCYTE INTERACTIONS$104,870
K08 · FY2000 · HL